(Q44459164)

English

Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose.

scientific article published on 29 May 2003

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

12775573

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12775573%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 November 2019

title

Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

12775573

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12775573%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

3

1 reference

stated in

Europe PubMed Central

PubMed ID

12775573

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12775573%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 November 2019

Shlomit Reich-Zeliger

series ordinal

2

object named as

Shlomit Reich-Zeliger

1 reference

stated in

Europe PubMed Central

PubMed ID

12775573

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12775573%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 November 2019

author name string

Esther Bachar-Lustig

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

12775573

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12775573%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 November 2019

language of work or name

English

0 references

publication date

29 May 2003

1 reference

stated in

Europe PubMed Central

PubMed ID

12775573

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12775573%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

Europe PubMed Central

PubMed ID

12775573

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12775573%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 November 2019

volume

102

1 reference

stated in

Europe PubMed Central

PubMed ID

12775573

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12775573%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 November 2019

issue

6

1 reference

stated in

Europe PubMed Central

PubMed ID

12775573

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12775573%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 November 2019

page(s)

1943-1950

1 reference

stated in

Europe PubMed Central

PubMed ID

12775573

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12775573%20AND%20SRC:MED&resulttype=core&format=json

(Q44459164)

Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)